Anders Erik Astrup Dahm

Image of Anders Erik Astrup Dahm
Norwegian version of this page
Username
Visiting address Sykehusveien 25 1474 Nordbyhagen
Postal address Akershus universitetssykehus 1478 Lørenskog

Publications

  • Larsen, Trine-Lise; Garresori, Herish; Brekke, Jorunn; Enden, Tone Rønnaug; Frøen, Hege & Jacobsen, Eva-Marie [Show all 15 contributors for this article] (2022). Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow-up. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 20(5), p. 1166–1181. doi: 10.1111/jth.15666.
  • Dalen, Viktor; Vegsgaard Olsen, Anne-Sofie; Pierre-Jerome, Claude; Geitung, Jonn Terje & Dahm, Anders Erik A (2021). Low diagnostic accuracy and inter-observer agreement on CT and MRI in diagnosis of spinal fractures in multiple myeloma. Hematology Reports. ISSN 2038-8322. 13(3). doi: 10.4081/hr.2021.9037. Full text in Research Archive
  • Dahm, Anders Erik A (2021). Cancer and Thrombosis: New Treatments, New Challenges. Medical Sciences. ISSN 2076-3271. 9(41), p. 1–11. doi: 10.3390/medsci9020041. Full text in Research Archive
  • Cui, Xueyan; Tjønnfjord, Geir Erland; Kanse, Sandip; Dahm, Anders Erik A; Iversen, Nina & Myklebust, Christiane Filion [Show all 12 contributors for this article] (2021). Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia. Scientific Reports. ISSN 2045-2322. 11. doi: 10.1038/s41598-021-84695-8. Full text in Research Archive
  • Berntsen, Christopher Friis; Rootwelt, Pernille & Dahm, Anders Erik A (2021). Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta-analysis. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 5(4), p. 1–11. doi: 10.1002/rth2.12507. Full text in Research Archive
  • Khialani, Deeksha; Vasan, Sowmya; Cushman, Mary; Dahm, Anders Erik A; Sandset, Per Morten & Rossouw, Jacques [Show all 7 contributors for this article] (2021). Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 19(7), p. 1729–1737. doi: 10.1111/jth.15319.
  • Hannevik, Trine-Lise; Brekke, Jorunn; Enden, Tone Rønnaug; Frøen, Hege; Ahmed, Herish & Jacobsen, Eva-Marie [Show all 15 contributors for this article] (2020). Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism. Thrombosis Research. ISSN 0049-3848. 196, p. 238–244. doi: 10.1016/j.thromres.2020.08.042.
  • Berentsen, Sigbjørn; Barcellini, Wilma; D'Sa, Shirley; Randen, Ulla; Tvedt, Tor Henrik Anderson & Fattizzo, Bruno [Show all 23 contributors for this article] (2020). Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood. ISSN 0006-4971. 136(4), p. 480–488. doi: 10.1182/blood.2020005674.
  • Frønæs, Synne Grønvold; Jørgensen, Camilla Tøvik; Dahm, Anders Erik A; Wik, Hilde Skuterud; Gleditsch, Jostein & Raouf, Nezar [Show all 9 contributors for this article] (2020). Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis. Blood Advances. ISSN 2473-9529. 4(20), p. 5002–5010. doi: 10.1182/BLOODADVANCES.2020002173. Full text in Research Archive
  • Frønæs, Synne Grønvold; Dahm, Anders Erik Astrup; Skuterud Wik, Hilde; Jørgensen, Camilla Tøvik; Gleditsch, Jostein & Raouf, Nezar [Show all 9 contributors for this article] (2020). Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis. Blood Advances. ISSN 2473-9529. 4(11), p. 2468–2476. doi: 10.1182/bloodadvances.2020001556. Full text in Research Archive
  • Dahm, Anders Erik A; Jacobsen, Eva-Marie; Wik, Hilde Skuterud; Jacobsen, Anne Flem; Mollnes, Tom Eirik & Kanse, Sandip [Show all 7 contributors for this article] (2019). Elevated complement C3 and C4 levels are associated with postnatal pregnancy-related venous thrombosis. Thrombosis and Haemostasis. ISSN 0340-6245. 119(9), p. 1481–1488. doi: 10.1055/s-0039-1692426. Full text in Research Archive
  • Eilertsen, Anette Løken; Dahm, Anders Erik A; Høibraaten, Else; Lofthus, Cathrine Marie; Mowinckel, Marie-Christine & Sandset, Per Morten (2019). Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood Coagulation and Fibrinolysis. ISSN 0957-5235. 30(1), p. 17–23. doi: 10.1097/MBC.0000000000000784.
  • Frønæs, Synne Grønvold; Wik, Hilde Skuterud; Dahm, Anders Erik A; Jørgensen, Camilla Tøvik; Gleditsch, Jostein & Raouf, Nezar [Show all 8 contributors for this article] (2018). Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 16(12), p. 2471–2481. doi: 10.1111/jth.14314. Full text in Research Archive
  • Kostovski, Emil; Frigato, E; Savikj, Mladen; Dahm, Anders Erik A; Sandset, Per Morten & Mowinckel, Marie-Christine [Show all 10 contributors for this article] (2018). Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation. Spinal Cord. ISSN 1362-4393. p. 1–8. doi: 10.1038/s41393-018-0176-x. Full text in Research Archive
  • Panagopoulos, Ioannis; Gorunova, Ludmila; Andersen, Hege Kilen; Bergrem, Astrid; Dahm, Anders Erik A & Andersen, Kristin [Show all 8 contributors for this article] (2018). PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia. Experimental hematology and oncology. ISSN 2162-3619. 7(7). doi: 10.1186/s40164-018-0099-4. Full text in Research Archive
  • Habberstad, Andreas Hanssønn; Tran, Hoa Thi Tuyet; Randen, Ulla; Spetalen, Signe; Dybedal, Ingunn & Tjønnfjord, Geir Erland [Show all 7 contributors for this article] (2018). Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: A case report. Journal of Medical Case Reports. ISSN 1752-1947. 12(1). doi: 10.1186/s13256-018-1663-6. Full text in Research Archive
  • Utne, Kristin Kornelia; Dahm, Anders Erik A; Wik, Hilde Skuterud; Jelsness-Jørgensen, Lars-Petter; Sandset, Per Morten & Ghanima, Waleed Khalid (2018). Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Thrombosis Research. ISSN 0049-3848. 163, p. 6–11. doi: 10.1016/j.thromres.2018.01.013.
  • Amundsen, Erik Koldberg; Skadberg, Øyvind; Ghanima, Waleed Khalid; Frønæs, Synne Grønvold; Dahm, Anders Erik A & Tøsdal, Margunn Bye [Show all 9 contributors for this article] (2018). D-Dimer: Aldersjusterte beslutningsgrenser ved diagnostikk av venøs tromboembolisme? Klinisk Biokemi i Norden. ISSN 1101-2013. 30(1), p. 26–36.
  • Cui, Xueyan; Skretting, Grethe; Tinholt, Mari; Stavik, Benedicte; Dahm, Anders Erik A & Kanse, Sandip [Show all 8 contributors for this article] (2017). A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in breast cancer. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 1, p. 395–395.
  • Cui, Xue-Yan; Skretting, Grethe; Tinholt, Mari; Stavik, Benedicte; Dahm, Anders Erik A & Sahlberg, Kristine Kleivi [Show all 9 contributors for this article] (2017). A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7. Thrombosis Research. ISSN 0049-3848. 157, p. 111–116. doi: 10.1016/j.thromres.2017.07.013.
  • Prebensen, Christian; Trøseid, Marius; Ueland, Thor; Dahm, Anders Erik A; Sandset, Per Morten & Aaberge, Ingeborg Sundsvalen [Show all 10 contributors for this article] (2017). Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. PLOS ONE. ISSN 1932-6203. 12(5). doi: 10.1371/journal.pone.0176527. Full text in Research Archive
  • Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders Erik A & Iversen, Nina [Show all 8 contributors for this article] (2016). Oestrogens downregulate tissue factor pathway inhibitor through oestrogen response elements in the 5′-flanking region. PLOS ONE. ISSN 1932-6203. 11(3). doi: 10.1371/journal.pone.0152114.
  • Johnson, Karen C; Aragaki, Aaron; Jackson, Rebecca; Reiner, Alex P; Sandset, Per Morten & Rosing, Jan [Show all 14 contributors for this article] (2016). Tissue factor pathway inhibitor, activated protein C resistance, and risk of coronary heart disease due to combined estrogen plus progestin therapy. Arteriosclerosis, Thrombosis and Vascular Biology. ISSN 1079-5642. 36(2), p. 418–424. doi: 10.1161/ATVBAHA.115.306905.
  • Cui, Xue-Yan; Tinholt, Mari; Stavik, Benedicte; Dahm, Anders Erik A; Kanse, Sandip & Jin, Yang [Show all 11 contributors for this article] (2016). Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 14(2), p. 387–396. doi: 10.1111/jth.13206.
  • Cui, Xueyan; Tinholt, Mari; Stavik, Benedicte; Dahm, Anders Erik A; Kanse, Sandip & Seidl, Sebastian [Show all 11 contributors for this article] (2015). Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer cell lines and tissues. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 13, p. 303–303.
  • Iversen, Per Ole; Dahm, Anders Erik A; Skretting, Grethe; Mowinckel, Marie-Christine; Haslestad, Annicke Stranda & Østerud, Bjarne [Show all 8 contributors for this article] (2015). Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study. Thrombosis and Haemostasis. ISSN 0340-6245. 114(5), p. 964–968. doi: 10.1160/TH15-05-0396.
  • Stiksrud, Birgitte; Nowak, Piotr; Nwosu, Felix Chinweije; Kvale, Dag; Thalme, Anders & Sönnerborg, Anders [Show all 15 contributors for this article] (2015). Reduced levels of D-dimer and changes in gut microbiota composition after probiotic intervention in HIV-infected individuals on stable ART. Journal of Acquired Immune Deficiency Syndromes. ISSN 1525-4135. 70(4), p. 329–337. doi: 10.1097/QAI.0000000000000784.
  • Kostovski, Emil; Dahm, Anders Erik A; Mowinckel, Marie-Christine; Stranda, Annicke; Skretting, Grethe & Østerud, Bjarne [Show all 8 contributors for this article] (2015). Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin. Spinal Cord. ISSN 1362-4393. 53, p. 285–290. doi: 10.1038/sc.2014.243. Full text in Research Archive
  • Cui, Xueyan; Skretting, Grethe; Dahm, Anders Erik A; Stavik, Benedicte; Iversen, Nina & Sandset, Per Morten (2014). Hypoxia contributes to procoagulant activity of breast cancer cells. Haematologica. ISSN 0390-6078. 99, p. 475–475.
  • Tinholt, Mari; Viken, Marte K; Dahm, Anders Erik A; Vollan, Hans Kristian Moen; Sahlberg, Kristine Kleivi & Garred, Øystein [Show all 16 contributors for this article] (2014). Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study. BMC Cancer. ISSN 1471-2407. 14. doi: 10.1186/1471-2407-14-845.
  • Kristiansen, Annette; Brandt, Linn; Agoritsas, Thomas; Akl, Elie A.; Berge, Eivind & Bondi, Johan Fridtjof [Show all 19 contributors for this article] (2014). Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process. Chest. ISSN 0012-3692. 146(3), p. 727–734. doi: 10.1378/chest.13-2828.
  • Vartdal, Trond; Fetveit, Arne; Kristiansen, Annette; Brandt, Linn; Halvorsen, Sigrun & Berge, Eivind [Show all 9 contributors for this article] (2014). Antitrombotisk behandling og profylakse: - ny generasjon retningslinjer for allmennleger. Utposten. ISSN 0800-5680. 3, p. 41–43.
  • Raps, M; Helmerhorst, FM; Fleischer, K; Dahm, Anders Erik A; Rosendaal, FR & Rosing, J [Show all 9 contributors for this article] (2013). The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Thrombosis and Haemostasis. ISSN 0340-6245. 109(4), p. 606–613. doi: 10.1160/TH12-10-0771.
  • Skretting, Grethe; Iversen, Nina; Myklebust, Christiane Filion; Dahm, Anders Erik A & Sandset, Per Morten (2012). Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-kappa B and apoptosis mediated by a caspase-3 independent pathway. Molecular Biology Reports. ISSN 0301-4851. 39(12), p. 10089–10096. doi: 10.1007/s11033-012-1882-7.
  • Dahm, Anders Erik A; Bezemer, Irene D; Bergrem, Astrid; Jacobsen, Anne Flem; Jacobsen, Eva-Marie & Skretting, Grethe [Show all 8 contributors for this article] (2012). Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis. British Journal of Haematology. ISSN 0007-1048. 157(6), p. 753–761. doi: 10.1111/j.1365-2141.2012.09121.x.
  • Dahm, Anders Erik A; Eilertsen, Anette Løken; Goeman, Jelle; Olstad, Ole Kristoffer; Øvstebø, Reidun & Kierulf, Peter [Show all 9 contributors for this article] (2012). A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thrombosis Research. ISSN 0049-3848. 130(1), p. 45–51. doi: 10.1016/j.thromres.2011.12.009.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2012). Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism A population-based case-control study. Thrombosis and Haemostasis. ISSN 0340-6245. 108(6), p. 1165–1171. doi: 10.1160/TH12-05-0350.
  • Pettersen, Frank Olav; Torheim, Eirik A.; Dahm, Anders Erik A; Aaberge, Ingeborg Sundsvalen; Lind, Andreas & Holm, Malin [Show all 10 contributors for this article] (2011). An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: Downregulated immune activation and improved T Cell-dependent vaccine responses. Journal of Virology. ISSN 0022-538X. 85(13), p. 6557–6566. doi: 10.1128/JVI.00073-11.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Mowinckel, Marie-Christine; Sandvik, Leiv & Sandset, Per Morten (2011). Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. British Journal of Haematology. ISSN 0007-1048. 154(2), p. 241–247. doi: 10.1111/j.1365-2141.2011.08712.x.
  • Kostovski, Emil; Dahm, Anders Erik A; Iversen, Nina; Hjeltnes, Nils; Østerud, Bjarne & Sandset, Per Morten [Show all 7 contributors for this article] (2011). Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagulation and Fibrinolysis. ISSN 0957-5235. 22(4), p. 254–259. doi: 10.1097/MBC.0b013e3283442ce2.
  • Jacobsen, Anne Flem; Dahm, Anders Erik A; Bergrem, Astrid; Jacobsen, Eva-Marie & Sandset, Per Morten (2010). Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 8(11), p. 2443–2449. doi: 10.1111/j.1538-7836.2010.04038.x.
  • Sandset, Per Morten; Høibraaten, Else; Eilertsen, Anette Løken & Dahm, Anders Erik A (2009). Mechanisms of thrombosis related to hormone therapy. Thrombosis Research. ISSN 0049-3848. 123, p. S70–S73. doi: 10.1016/S0049-3848%2809%2970015-5.
  • van Vliet, Huib AAM; Bertina, Rogier M; Dahm, Anders Erik A; Rosendaal, Frits; Rosing, Jan & Sandset, Per Morten [Show all 7 contributors for this article] (2008). Different effects of oral contraceptives containing different progestogens on protein S and Tissue Factor Pathway Inhibitor. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 6(2), p. 346–351. doi: 10.1111/j.1538-7836.2007.02863.x.
  • Dahm, Anders Erik A; Iversen, Per Ole; Hjeltnes, Nils & Sandset, Per Morten (2006). Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured. Thrombosis Research. ISSN 0049-3848. 118(2), p. 281–287.
  • Dahm, Anders Erik A; Iversen, Nina; Birkenes, Bård; Ree, Anne Hansen & Sandset, Per Morten (2006). Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovascular Disorders. ISSN 1471-2261. 6. doi: 10.1186/1471-2261-6-40.
  • Dahm, Anders Erik A; Osterud, B; Hjeltnes, N; Sandset, PM & Iversen, Per Ole (2006). Opposite circadian rythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation? Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 4(8), p. 1840–1842.
  • Iversen, Per Ole; Dahm, Anders Erik A & Sandset, Per Morten (2005). Circadian variations within the hemostatic and fibrinolytic systems with emphasis on venous thromboembolism. In Columbus, Frank (Eds.), Trends in Chronobiology Research. Nova Science Publishers, Inc.. ISSN 1-59454-482-4. p. 281–297.
  • Negaard, Helene; Dahm, Anders Erik A; Sandset, Per Morten; Østenstad, Bjørn & Iversen, Per Ole (2005). Angiogenesis and hemostasis in hematological neoplasias. Current Drug Targets. ISSN 1389-4501. 6, p. 683–699.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2005). A novel anticoagulant activity assay of tissue factor pathway inhibitor 1 (TFPI). Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 3, p. 651–658.
  • Visser, MC; Hylckama Vlieg, Astrid; Tans, Guido; Rosing, Jan; Dahm, Anders Erik A & Sandset, Per Morten [Show all 8 contributors for this article] (2005). Determinants of the APTT- and ETP-based APC sensitivity tests. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 3(7), p. 1488–1494.
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2003). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood. ISSN 0006-4971. 101(11), p. 4387–4392.
  • Dahm, Anders Erik A & Brørs, Odd (2002). Phenytoin toxicity caused by interaction with ticlopidin. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 37, p. 4–9.
  • Blomhoff, Svein; Jacobsen, M.B.; Spetalen, S.; Dahm, Anders Erik A & Malt, Ulrik Fredrik (2000). Perceptual hyperreactivity to auditory stimuli in patients with Irritabel Bowel Syndrome. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 35, p. 583–589.

View all works in Cristin

  • Dahm, Anders Erik A & Sandset, Per Morten (2021). Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences? Blood Advances. ISSN 2473-9529. 5(11), p. 2516–2517. doi: 10.1182/BLOODADVANCES.2021004651. Full text in Research Archive
  • Cui, Xueyan; Tjønnfjord, Geir Erland; Kanse, Sandip; Iversen, Nina; Dahm, Anders Erik A & Myklebust, Christiane Filion [Show all 11 contributors for this article] (2019). Tissue factor pathway inhibitor enhances transendothelial migration of chronic lymphocytic leukemia cells trhough CXCL12/CXCR7 chemotaxis. Research and Practice in Thrombosis and Haemostasis. ISSN 2475-0379. 3.
  • Dahm, Anders Erik Astrup & Hannevik, Trine-Lise (2019). Forebygging av venøs tromboembolisme ved kreft - hvilke pasienter kan DOAK være relevante for? . Best Practice Nordic. ISSN 1902-7583.
  • Sandset, Per Morten & Dahm, Anders Erik Astrup (2019). Is venous thromboembolism a problem in patients with cancer in palliative care? The Lancet Haematology. ISSN 2352-3026. doi: 10.1016/S2352-3026%2818%2930218-7.
  • Dahm, Anders Erik A; Jacobsen, Eva-Marie; Jacobsen, Anne Flem; Skuterud Wik, Hilde & Sandset, Per Morten (2017). High complement C3 increases the risk for postnatal venous thrombosis.
  • Dahm, Anders Erik A & Ghanima, Waleed Khalid (2017). Nye direktevirkende antikoagulasjonsmidler til kreftpasienter? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 137(3), p. 171–172. doi: 10.4045/tidsskr.17.0008.
  • Utne, Kristin Kornelia; Wik, Hilde Skuterud; Jelsness-Jørgensen, Lars-Petter; Sandset, Per Morten; Dahm, Anders Erik A & Tavoly, Mazdak [Show all 7 contributors for this article] (2017). Rivaroxaban Reduces the Rate of Post-Thrombotic Syndrome After DVT - a Cross-Sectional Study Comparing Rivaroxaban to Warfarin.
  • Dahm, Anders Erik A; Tiscia, Gianluca; Holmgren, Asbjørn; Jacobsen, Anne Flem; Skretting, Grethe & Grandone, E. [Show all 7 contributors for this article] (2015). Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 13(3), p. 409–413. doi: 10.1111/jth.12817.
  • Stiksrud, Birgitte; Nowak, Piotr; Kvale, Dag; Thalme, Anders; Birkeland, Stein-Erik & Dahm, Anders Erik A [Show all 8 contributors for this article] (2014). Reduced D-dimer levels and inflammation markers after probiotic supplement in HIV-infected on ART.
  • Jacobsen, Eva-Marie; Dahm, Anders Erik A; Vartdal, Trond & Sandset, Per Morten (2014). Antikoagulasjon ved venøs trombose og indremedisinsk sykdom. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 134(9), p. 924–924.
  • Kristiansen, Annette; Brandt, Linn; Berge, Eivind; Dahm, Anders Erik A; Halvorsen, Sigrun & Sandset, Per Morten [Show all 7 contributors for this article] (2014). Nye retningslinjer for antitrombotisk behandling og tromboseprofylakse. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 134(9), p. 921–922. doi: 10.4045/tidsskr.13.1582.
  • Tinholt, Mari; Viken, MK; Borresen-Dale, AL; Kristensen, V; Karesen, R & Schlichting, E [Show all 12 contributors for this article] (2013). The link between the hemostatic system and cancer: A genotype-phenotype study in breast cancer patients. Thrombosis Research. ISSN 0049-3848. 131, p. S75–S76.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2013). Differential risk factors for pregnancy-related deep vein thrombosis and pulmonary embolism - Results from a population-based case-control study. Thrombosis Research. ISSN 0049-3848. 131, p. S75–S75.
  • Skretting, Grethe; Iversen, Nina; Myklebust, Christiane Filion; Dahm, Anders Erik A & Sandset, Per Morten (2012). Apoptosis in CHO-K1 cells overexpressing TFPI involves both intrinsic and extrinsic pathways additional to induced activation of NF-kappa B. Thrombosis Research. ISSN 0049-3848. 129, p. S192–S192.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2012). Differential risk factors for pregnancy related deep vein thrombosis and pulmonary embolism' results from a population-based case-control study. Thrombosis Research. ISSN 0049-3848. 130, p. S122–S123. doi: 10.1016/j.thromres.2012.08.059.
  • Dahm, Anders Erik A; Eilertsen, Anette Løken; Goeman, J.; Olstad, Ole Kristoffer; Øvstebø, Reidun & Kierulf, Peter [Show all 9 contributors for this article] (2011). A microarray study on the effect of four hormone therapy regimens on gene transcription in leucocytes from healthy postmenopausal women. Thrombosis Research. ISSN 0049-3848. 127, p. S124–S124.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Mowinckel, Marie-Christine; Sandvik, Leiv & Sandset, Per Morten (2011). Reduced sensitivity to activated protein C in the absence of the factor V Leiden polymorphism is a risk factor for pregnancy related venous thrombosis. Thrombosis Research. ISSN 0049-3848. 127, p. S127–S127.
  • Dahm, Anders Erik A; Bezemer, ID; Sandset, Per Morten & Rosendaal, Frits (2010). Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 8(5), p. 1130–1132. doi: 10.1111/j.1538-7836.2010.03805.x.
  • Dahm, Anders Erik A; Bezemer, Irene D; Bergrem, Astrid; Jacobsen, Anne Flem; Jacobsen, Eva-Marie & Skretting, Grethe [Show all 8 contributors for this article] (2010). Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis. Blood. ISSN 0006-4971. 116(21), p. 1708–1709.
  • Dahm, Anders Erik A; Sandset, Per Morten & Rosendaal, Frits (2008). The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1. Journal of Thrombosis and Haemostasis. ISSN 1538-7933. 6, p. 393–395. doi: 10.1111/j.1538-7836.2007.02859.x.
  • Negaard, Helene FS; Eilertsen, Anette Løken; Dahm, Anders Erik A; Iversen, Per Ole; Østenstad, Bjørn & Sandset, Per Morten (2006). Decreased lung cancer survival with hormone replacement therapy – Due to decreased tissue factor pathway inhibitor level? Journal of Clinical Oncology. ISSN 0732-183X. 24(17), p. 2683–2684.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). A novel assay for tissue factor pathway inhibitor (TFPI) anticoagulant activity in plasma.
  • Dahm, Anders Erik A; Høibraaten, Else; Morrissey, Jim; Andersen, Trine Opstad & Sandset, Per Morten (2004). The influence of hormone replacement therapy (HRT) on the factor VIIa/antithrombin (FVIIa/AT) complex.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). A novel assay for tissue factor pathway inhibitor (TFPI) anticoagulant activity in plasma.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). Biological relevance of a new TFPÌ anticoagulant activity assay of full-length TFPI.
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Tissue factor pathway inhibitor (TFPI) and risk of deep venous thrombosis (DVT).
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Tissue factor pathway inhibitor (TFPI) and the risk of deep venous thrombosis (DVT).
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

View all works in Cristin

Published Mar. 6, 2014 12:55 PM - Last modified June 1, 2016 8:52 AM